Gene-based clinical trials typically target a very small subset of the patient population.  That makes finding patients extremely challenging and implementing effective engagement strategies critical.  In addition, regulations regarding the use, storage, and disclosure of genetic test results have changed significantly, resulting in potential compliance risks to clinical trial sponsors.

In this webinar, Karmen Trzupek, M.S., CGC, Director of Rare Disease Genetics Services and Clinical Trial Services at InformedDNA®, explores how to address and overcome challenges in genetics-based clinical trials, using real-life case studies. InformedDNA is the authority on the appropriate use of genetic testing and the leading telemedicine provider of clinical genetics services. Topics to be covered include:

  • Effective patient identification
  • Strengthening patient engagement and retention
  • Collection, use, and disclosure of genetic data
  • Planning for a post-market environment

Who should attend? Anyone involved in designing or operating clinical trials for rare disease therapies.

Featured Speaker

Karmen Trzupek

Director, Rare Disease Genetics Services and Clinical Trial Services
InformedDNA

Karmen Trzupek directs clinical trial services at InformedDNA. A board-certified genetic counselor for 19 years, she is now focused on developing strategies and programs to increase the efficiency of patient identification and enrollment for clinical trials. She holds an M.S. in Genetic Counseling from Northwestern University and a B.S. in Microbiology from the University of Illinois. 

Date:  Tuesday, April 28, 2020
Time:  2pm EST / 11am PST
Duration:  1 Hour

Register now for this webinar